Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Theratechnologies (THTX) stock gains as a new formulation of its best selling drug Egrifta is cleared by the FDA. Read more ...